Analyst Price Targets — NVCT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 4, 2025 1:55 pm | — | H.C. Wainwright | $10.00 | $7.29 | TheFly | Nuvectis Pharma price target lowered to $10 from $15 at H.C. Wainwright |
Latest News for NVCT
Fort Lee, NJ, March 31, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced upcoming presentations for NXP900 at the upcoming 2026 American Association for Cancer Research Meeting…
FORT LEE, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today reported its financial results for the year ended December 31, 2025 and provided an update on recent business…
Nuvectis Pharma, Inc. (NASDAQ: NVCT - Get Free Report) shot up 5.8% on Wednesday. The company traded as high as $8.63 and last traded at $8.58. 58,015 shares were traded during mid-day trading, a decline of 7% from the average session volume of 62,470 shares. The stock had previously closed at $8.11. Wall Street Analysts
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NVCT.
U.S. House Trading
No House trades found for NVCT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.